Latham & Watkins represented Chardan Healthcare Acquisition 2 Corp. in the transaction. Renovacor, Inc. (Renovacor), an early-stage biotechnology company developing AAV-based gene therapies for devastating cardiovascular...
Chardan Healthcare Acquisition 2 Corp.’s Merger with Renovacor
Par Pacific’s $75.7 Million Common Stock Offering
Latham & Watkins LLP represented the underwriters in the transaction. Par Pacific Holdings, Inc. executed its underwritten public offering of 5,000,000 shares of its common stock...
USHG Acquisition Corp.’s $250 Million Initial Public Offering
Latham & Watkins LLP represented USHG Acquisition Corp. in the offering. USHG Acquisition Corp. has announced the pricing of its initial public offering of 25,000,000 units...
Great Western Petroleum’s Senior Secured Notes Offering, Credit Agreement Amendment, and Comprehensive Equity Recapitalization
Latham & Watkins LLP advised Great Western Petroleum, LLC in the transactions. Great Western Petroleum, LLC (the Company) has completed its previously announced comprehensive equity recapitalization transaction...